Additionally, the intensity of anti-CD34+ staining was significantly higher in the AD group (58.21%) compared to the other two groups, which showed values of 24.7% for the control group and 32.64% for the PPE + AD group, Figure 4A. The gene discussed is CD34; the disease is Alzheimer disease.